ReShape Lifesciences shareholders approve reverse split, stock issuance; asset sale vote postponed to Aug 7

Vyome Holdings, Inc

Proposals 1,4,5,6 approved; meetings on asset sale (Prop 2) and merger charter (Prop 3) adjourned to Aug 7.
Prop 1 (shares for merger) passed: 583,748 for, 59,520 against, 235,196 abstain, 604,121 broker non-votes.
Prop 4 (reverse stock split 1:2 to 1:5) approved: 1,249,487 for, 227,492 against, 5,606 abstain.
Reconvened meeting Aug 7 at 11:30am ET virtual; record date remains June 9, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.